Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Sulodexide on damaged endothelial glycocalyx in patients with type 2 diabetes mellitus
2006-004043-35Phase 4Active
- Start
- Feb 2007
- Countries
- 1
01
Overview
Phase 4 trial of sulodexide in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis. Primary endpoint: Main study parameter/endpoint. Started Feb 2007; status: active.
02
Drugs
sulodexide
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on 2006-004043-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004043-35.